New mRNA Flu Vaccine Approved for Adults 50 and Older Ahead of Flu Season
The FDA has approved Mfluziva, an mRNA flu vaccine by Moderna, for adults aged 50 and older, showing 27% more effectiveness than standard flu shots. This innovative vaccine utilizes mRNA technology similar to COVID-19 vaccines, allowing for faster production.
Where it's breaking
Local coverage
New mRNA Flu Vaccine Approved for Adults 50 and Older Ahead of Flu Season
New mRNA Flu Vaccine Approved for Adults 50 and Older Ahead of Flu Season
New mRNA Flu Vaccine Approved for Adults 50 and Older Ahead of Flu Season
What To Know About COVID-19, Flu and RSV Vaccines for Sick Season in New York
Free Flu Vaccine Clinics Launch Across Arkansas
County offers free fall flu vaccination clinics
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.